Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-26-171799
Filing Date
2026-04-23
Accepted
2026-04-23 07:00:34
Documents
16
Period of Report
2026-06-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d113727ddef14a.htm   iXBRL DEF 14A 592707
3 GRAPHIC g113727g16w01.jpg GRAPHIC 250937
4 GRAPHIC g113727g16w02.jpg GRAPHIC 229627
5 GRAPHIC g113727g47x01.jpg GRAPHIC 133186
6 GRAPHIC g113727g47x02.jpg GRAPHIC 136243
  Complete submission text file 0001193125-26-171799.txt   3098182

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nerv-20251231.xsd EX-101.SCH 11381
21 EXTRACTED XBRL INSTANCE DOCUMENT d113727ddef14a_htm.xml XML 147696
Mailing Address 1500 DISTRICT AVENUE BURLINGTON MA 01803
Business Address 1500 DISTRICT AVENUE BURLINGTON MA 01803 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

EIN.: 260784194 | State of Incorp.: MA | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36517 | Film No.: 26885480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)